気管支拡張症の重症度と血清TNFαの評価:FACEDおよびBSIスコアリングシステムからの洞察
Santhiya Ramachandran1, Yuvarajan Sivagnaname2, Antonious Maria Selvam3
1Department of Respiratory Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed to be University, Puducherry, India.
Lung India : official organ of Indian Chest Society
|December 31, 2025
まとめ
腫瘍壊死因子α(TNFα)の血清レベルは、気管支拡張症の重症度と相関する。TNFαの上昇は、重症度、増悪、感染を示唆し、バイオマーカーとしての可能性を示唆する。
科学分野:
- 肺医学
- 免疫学
- バイオマーカー研究
背景:
- 気管支拡張症は、気管支拡張と炎症を伴う慢性肺疾患である。
- 腫瘍壊死因子α(TNFα)は炎症に関与しているが、気管支拡張症の重症度におけるその役割は不明である。
研究 の 目的:
- 血清TNFαレベルと気管支拡張症の重症度との関連を評価する。
- TNFαを疾患評価の潜在的なバイオマーカーとして探求する。
主な方法:
- 気管支拡張症患者96人を対象とした横断研究。
- 血清TNFαレベルを測定した。
- TNFαと臨床データ、放射線学的所見、重症度スコア(FACED、BSI)との相関を調べた。
主要な成果:
- 高い血清TNFαレベルは、発熱、白血球増加、入院、増悪と関連していた。
- 多葉/両側性疾患および緑膿菌コロニー形成を有する患者では、TNFαが著しく上昇した(P=0.01)。
- FACEDおよびBSIスコアによる中等度/重度の気管支拡張症と高TNFαとの強い関連。
結論:
- 血清TNFαは、気管支拡張症の重症度に対する潜在的なバイオマーカーである。
- TNFαの上昇は、増悪、微生物コロニー形成、および重症度と相関する。
- TNFαは、気管支拡張症の予後および管理戦略に役立つ可能性がある。
関連する概念動画
Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Pulmonary Tuberculosis III
884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
884
Pneumonia III: Complications and Assessment
756
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
756


